MARATTO

article · Journal of Heterocyclic Chemistry

Design, Synthesis, Antiproliferative Screening, and In Silico Studies of Some Pyridinyl‐Pyrimidine Candidates

20245 citationsAin Shams University

Abstract

ABSTRACT Using pyrimidinethione, a new series of pyridinyl‐pyrimidine candidates was prepared by reacting with diverse carbon‐centered electrophiles like hydrazonoyl chloride, N ‐arylchloroacetamide, ethyl chloroacetate, and enaminone derivatives. Some heteroannulated compounds, such as triazolopyrimidine and thiazolopyrimidine derivatives were obtained. The mass fragmentation pathways were investigated by the electron impact mass spectrometry (EI‐MS), and the molecular ion peaks (M +. ) were recorded at different intensities. The in vitro antiproliferative efficacy of the prepared compounds against MCF7 and HCT116 cancer cell lines showed the highest potency of pyrimidinethione 2 , triazolopyrimidine 4 , and thiazolopyrimidine 10 . Also, in silico studies were performed to recognize these findings. A molecular docking simulation towards the EGFR enzyme showed the best docking score of thiazolopyrimidine 10 through H‐bonding and hydrophobic interactions in comparison to the interactions of co‐crystallized ligand and doxorubicin. With DFT calculations, compound 10 exhibited the lowest energy gap and the highest softness. Among ADME simulation, compounds 7 , 8 , 9 , and 11 exhibited desirable lead‐likeness. It is hoped that this work may affect advancing new effective antiproliferative agents.

Research topics

  • Synthesis and biological activity
  • Computational Drug Discovery Methods
  • Chemical Synthesis and Analysis

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/jhet.4945

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.